Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population

by Garrett Green, Ellen Kim, Ruben Carmona, Hanjie Shen, James D. Murphy, Loren K. Mell
Published 2018-10-01

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities

by Robert Saddawi-Konefka, Robert Saddawi-Konefka, Aaron B. Simon, Aaron B. Simon, Whitney Sumner, Whitney Sumner, Andrew Sharabi, Andrew Sharabi, Loren K. Mell, Loren K. Mell, Ezra E. W. Cohen, Ezra E. W. Cohen
Published 2021-09-01

Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.

by Garrett Green, Ruben Carmona, Kaveh Zakeri, Chih-Han Lee, Saif Borgan, Zaid Marhoon, Andrew Sharabi, Loren K Mell
Published 2016-01-01

End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma

by Whitney Sumner, Sangwoo S. Kim, Lucas Vitzthum, Kevin Moore, Todd Atwood, James Murphy, Sayuri Miyauchi, Joseph A. Califano, Loren K. Mell, Arno J. Mundt, Andrew B. Sharabi
Published 2021-08-01

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response

by Kripa Guram, Maria Nunez, John Einck, Loren K. Mell, Ezra Cohen, P. Dominick Sanders, Sayuri Miyauchi, Elizabeth Weihe, Razelle Kurzrock, Razelle Kurzrock, Sarah Boles, Andrew B. Sharabi
Published 2018-10-01

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

by Andrew G. Sikora, Kevin J. Harrington, R. Bryan Bell, Maura L. Gillison, Quynh-Thu Le, Nancy Y. Lee, Rebecca L. Lewis, Loren K. Mell, Adam Raben, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg
Published 2019-03-01

Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy

by Lucas K. Vitzthum, Elena S. Heide, Helen Park, Casey W. Williamson, Paige Sheridan, Minh-Phuong Huynh-Le, Igor Sirak, Lichun Wei, Rafal Tarnawski, Umesh Mahantshetty, Cammie Nguyen, Jyoti Mayadev, Catheryn M. Yashar, Assuntina G. Sacco, Loren K. Mell
Published 2020-07-01

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer

by Julie E. Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L. Ferris, Josephine Chen, Richard C. Jordan, Nikhil P. Joshi, Srinivas Jujjuvaparu, Dukagjin M. Blakaj, Christina Henson, Jawad Sheqwara, Loren K. Mell, Neilayan Sen, David A. Clump, Madhur K. Garg, Emrullah Yilmaz, Pedro Torres-Saavedra, Quynh-Thu Le
Published 2021-06-01